-+ 0.00%
-+ 0.00%
-+ 0.00%

Cero Therapeutics signs SRX Global secured note for up to $11.67 million

PUBT·08/31/2026 20:53:17
Listen to the news
Cero Therapeutics signs SRX Global secured note for up to $11.67 million
  • Cero Therapeutics completed a secured financing with SRX Global on Aug. 27, 2026, issuing a Consolidated Senior Secured Promissory Note.
  • Note consolidates USD 5.67 million of previously outstanding debt held by SRX and debt originally held by Keystone Capital Partners.
  • Facility allows up to USD 6 million of additional SRX advances, taking maximum aggregate loan amount to USD 11.67 million.
  • SRX funded an initial USD 775,665 advance; USD 50,000 was withheld to cover SRX legal expenses.
  • Note bears 10% interest, rising to up to 24.99% on default; matures Oct. 15, 2026, with up to four 30-day extensions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cero Therapeutics Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-095776), on August 31, 2026, and is solely responsible for the information contained therein.